Cargando…

Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis

A natural killer group 2 member D (NKG2D) acts as a powerful activating and co-stimulatory receptor on immune effector cells including NK and T cells. Disruptions within the NKG2D signalling pathway may trigger an exacerbated immune response and promote autoimmune reactions. The objective of the stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iwaszko, Milena, Świerkot, Jerzy, Kolossa, Katarzyna, Jeka, Sławomir, Wiland, Piotr, Bogunia-Kubik, Katarzyna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852560/ https://www.ncbi.nlm.nih.gov/pubmed/29370129 http://dx.doi.org/10.3390/genes9020064

Ejemplares similares

Addendum: Iwaszko et al., Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis. Genes 2018, 9, 64
por: Iwaszko, Milena, et al.
Publicado: (2018)

Association of MICA-129Met/Val polymorphism with clinical outcome of anti-TNF therapy and MICA serum levels in patients with rheumatoid arthritis
por: Iwaszko, Milena, et al.
Publicado: (2020)

IL-33 Gene Polymorphisms as Potential Biomarkers of Disease Susceptibility and Response to TNF Inhibitors in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Patients
por: Iwaszko, Milena, et al.
Publicado: (2021)

Th2 Cytokines (Interleukin-5 and -9) Polymorphism Affects the Response to Anti-TNF Treatment in Polish Patients with Ankylosing Spondylitis
por: Biały, Sylwia, et al.
Publicado: (2022)

Polymorphisms within the RANK and RANKL Encoding Genes in Patients with Rheumatoid Arthritis: Association with Disease Progression and Effectiveness of the Biological Treatment
por: Wielińska, Joanna, et al.
Publicado: (2020)

Shared epitope and polymorphism of MICA and NKG2D encoding genes in Greek and Polish patients with rheumatoid arthritis
por: Wielińska, Joanna, et al.
Publicado: (2021)

Relationship Between Interleukin-6 −174G/C Genetic Variant and Efficacy of Methotrexate Treatment in Psoriatic Arthritis Patients
por: Sokolik, Renata, et al.
Publicado: (2021)

Significance of Polymorphism and Expression of miR-146a and NFkB1 Genetic Variants in Patients with Rheumatoid Arthritis
por: Bogunia-Kubik, Katarzyna, et al.
Publicado: (2017)

Polymorphisms within Genes Involved in Regulation of the NF-κB Pathway in Patients with Rheumatoid Arthritis
por: Gębura, Katarzyna, et al.
Publicado: (2017)

Disease Differentiation and Monitoring of Anti-TNF Treatment in Rheumatoid Arthritis and Spondyloarthropathies
por: Bogunia-Kubik, Katarzyna, et al.
Publicado: (2021)

Polymorphisms within Genes Coding for IL-17A and F and Their Receptor as Clinical Hallmarks in Ankylosing Spondylitis
por: Wielińska, Joanna, et al.
Publicado: (2021)

IL-17A, IL-17F and IL-23R Gene Polymorphisms in Polish Patients with Rheumatoid Arthritis
por: Bogunia-Kubik, Katarzyna, et al.
Publicado: (2014)

Changes in MiRNA-5196 Expression as a Potential Biomarker of Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis Patients
por: Ciechomska, Marzena, et al.
Publicado: (2018)

VDR Polymorphic Variants Are Related to Improvements in CRP and Disease Activity in Patients with Axial Spondyloarthritis That Undergo Anti-TNF Treatment
por: Bugaj, Bartosz, et al.
Publicado: (2022)

Exploring the Extracellular Vesicle MicroRNA Expression Repertoire in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis Treated with TNF Inhibitors
por: Wielińska, Joanna, et al.
Publicado: (2021)

Assessment of the Effect of Methotrexate Therapy on Bone Metabolism in Patients with Rheumatoid Arthritis
por: Świerkot, Jerzy, et al.
Publicado: (2015)

Significance of Interleukin (IL)-4 and IL-13 in Inflammatory Arthritis
por: Iwaszko, Milena, et al.
Publicado: (2021)

Methotrexate treatment for rheumatoid arthritis in Poland: Retrospective analysis of patients in routine clinical practice
por: Świerkot, Jerzy, et al.
Publicado: (2018)

Searching for New Genetic Biomarkers of Axial Spondyloarthritis
por: Bugaj, Bartosz, et al.
Publicado: (2022)

Assessment of the usefulness of skin autofluorescence as an indicator of disease activity and of the risk of developing diabetes in patients suffering from rheumatoid arthritis
por: Jeka, Sławomir, et al.
Publicado: (2015)

Patients with the most advanced rheumatoid arthritis remain with Th1 systemic defects after TNF inhibitors treatment despite clinical improvement
por: Kosmaczewska, Agata, et al.
Publicado: (2013)

Prevalence and clinical characteristics of rheumatoid arthritis in Poland: a nationwide study
por: Batko, Bogdan, et al.
Publicado: (2017)

Activating NKG2C Receptor: Functional Characteristics and Current Strategies in Clinical Applications
por: Siemaszko, Jagoda, et al.
Publicado: (2023)

NKG2D Natural Killer Cell Receptor—A Short Description and Potential Clinical Applications
por: Siemaszko, Jagoda, et al.
Publicado: (2021)

Alterations in Both the Activatory and Inhibitory Potential of Peripheral Blood CD4+ T Cells in Rheumatoid Arthritis Patients Correlate with Disease Progression
por: Kosmaczewska, Agata, et al.
Publicado: (2013)

Exogenous IL-2 Controls the Balance in Th1, Th17, and Treg Cell Distribution in Patients with Progressive Rheumatoid Arthritis Treated with TNF-Alpha Inhibitors
por: Kosmaczewska, Agata, et al.
Publicado: (2014)

Validation of GWAS-Identified Variants for Anti-TNF Drug Response in Rheumatoid Arthritis: A Meta-Analysis of Two Large Cohorts
por: Sánchez-Maldonado, Jose Manuel, et al.
Publicado: (2021)

The impact of NKG2A and NKG2D receptors and HLA-E and MICA ligands polymorphisms on post-transplant complications after paediatric allogeneic HSCT: a single-centre experience
por: Siemaszko, Jagoda, et al.
Publicado: (2023)

The role of diet in rheumatoid arthritis
por: Skoczyńska, Marta, et al.
Publicado: (2018)

The exposure to biologic and targeted synthetic disease-modifying antirheumatic drugs in pregnancy and lactation
por: Góralczyk, Alicja, et al.
Publicado: (2020)

Tofacitinib in the treatment of patients with rheumatoid arthritis: position statement of experts of the Polish Society for Rheumatology
por: Kucharz, Eugeniusz J., et al.
Publicado: (2018)

BSG and MCT1 Genetic Variants Influence Survival in Multiple Myeloma Patients
por: Łacina, Piotr, et al.
Publicado: (2018)

Results from Polish Spondyloarthritis Initiative registry (PolSPI) – methodology and data from – the first year of observation
por: Guła, Zofia, et al.
Publicado: (2017)

The changing role of ultrasonography examination in patients with rheumatoid arthritis in light of recent studies
por: Dura, Marta, et al.
Publicado: (2020)

Osteoporosis diagnostics in patients with rheumatoid arthritis
por: Węgierska, Małgorzata, et al.
Publicado: (2016)

Economic evaluation of anti-TNF agents for patients with rheumatoid arthritis in Greece
por: Fragoulakis, Vasilis, et al.
Publicado: (2015)

Tocilizumab as a first-line biologic treatment in rheumatoid arthritis patients – the impact of concomitant methotrexate treatment and Rheumatic Disease Comorbidity Index on the clinical response – results from the multicenter observational ACT-POL study
por: Stajszczyk, Marcin, et al.
Publicado: (2022)

Pharmacoeconomic evaluation of costs of rheumatoid arthritis therapy with selected biological treatment
por: Kowalik, Krzysztof, et al.
Publicado: (2018)

Coexistence of rheumatoid arthritis and ankylosing spondylitis
por: Barczyńska, Tacjana Anna, et al.
Publicado: (2015)

Do anti-TNF agents have equal efficacy in patients with rheumatoid arthritis?
por: Schwartzman, Sergio, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_03taune2ug25pg4a12uo2221vm